Source: Eur Respir J 2003; 22: 290-297
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gabrijelcic J., Acuna A., Profita M., Paterno A., Chung K.F., Vignola A.M., Rodriguez-Roisin R.. Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression. Eur Respir J 2003; 22: 290-297

Member's Comments

No comment yet.

Related content which might interest you: Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006 Effects of platelet-activating factor (PAF) challenge on airway neutrophilia and adhesion molecules in mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 Rhinovirus induces airway fibroblast release of neutrophil but not eosinophil chemokines Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation Source: Eur Respir J 2002; 19: 1142-1150 Year: 2002 IL-33/sST2 balance regulates neutrophilic inflammation in the human airways. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005 Formoterol protects against platelet-activating factor-induced effects in asthma Source: Eur Respir J 2004; 23: 71-75 Year: 2004 Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Source: Eur Respir J 2002; 19: 872-878 Year: 2002 Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism Source: Eur Respir J 2010; 35: 883-893 Year: 2010 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Bronchiectasis disease relevant PAMPs stimulate VEGF and neutrophil elastase release from neutrophils Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017